Science Explorer Back to mapMap
Discussion
Researcher · University of Santo Tomas Hospital · Philippines

Sandra Navarra

Sandra Navarra publishes mostly in Rheumatology, Pathology and Forensic Medicine and Epidemiology, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Multiple Sclerosis Research Studies.

ORCID 0000-0003-0094-8654 OpenAlex
World rank
#306,057
of 7,710,434 ranked researchers
Rank in Philippines
#79
of 6,138
Works
186
Citations
9.5k
Citations per work
51.2
h-index
39
i10-index 66Top 6% in Rheumatology
Sandra Navarra

What does Sandra Navarra research?

Sandra Navarra's work is mostly in Medicine (66%), Immunology and Microbiology (4%).

Health Sciences: 124 works · 66.5% of their workMedicine: 124 works · 66.5% of their workRheumatology: 81 works · 43.7% of their workPathology and Forensic Medicine: 17 works · 9.2% of their workEpidemiology: 9 works · 5.0% of their workHepatology: 9 works · 4.6% of their workSurgery: 7 works · 4.0% of their workEverything else: 54 works · 29.3% of their workLife Sciences: 8 works · 4.2% of their workImmunology and Microbiology: 8 works · 4.2% of their workImmunology: 8 works · 4.2% of their workTHEIR WORKSandra Navarra186works
Life Sciences4%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine12466.5%
  2. Everything else5429.3%
    1. Immunology and Microbiology84.2%
  1. 1Rheumatology44% of their works
  2. 2Pathology and Forensic Medicine9% of their works
  3. 3Epidemiology5% of their works
  4. 4Hepatology5% of their works
  5. 5Immunology4% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Sandra Navarra's research?

The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Inflammation, Rheumatoid Arthritis, Immunosuppressive Therapy, Diagnostic Criteria and Multiple Sclerosis.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Autoantibodies2163 topics
  2. Antiphospholipid Syndrome1451 topic
  3. Systemic Lupus Erythematosus1451 topic
  4. Inflammation521 topic
  5. Rheumatoid Arthritis521 topic
  6. Immunosuppressive Therapy362 topics
  7. Diagnostic Criteria211 topic
  8. Multiple Sclerosis211 topic
  9. Fibrosis191 topic
  10. Systemic Sclerosis191 topic
  11. Autoimmune Hepatitis171 topic
  12. Cytomegalovirus171 topic
  13. Infection171 topic
  14. Primary Biliary Cirrhosis171 topic
  15. Ankylosing Spondylitis141 topic
  16. Fc Receptors141 topic
  17. Spondyloarthritis141 topic
  18. Therapeutic Antibodies141 topic

Where does Sandra Navarra work?

Sandra Navarra's main affiliation in the publication record is University of Santo Tomas Hospital, Philippines.

How many publications and citations does Sandra Navarra have?

OpenAlex counts 186 works and 9,523 citations for Sandra Navarra, an h-index of 39, ranking #306,057 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Sandra Navarra

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sandra Navarra. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.